GLP-1(7-36)amide (GLP-1) is a physiological regulator of human antro-pyloro-duodenal motility.

被引：0
|
作者：
Schirra, JJ
Wank, U
Arnold, R
Goeke, B
Katschinski, M
机构：
[1] Univ Marburg, Marburg, Germany
[2] Univ Bern, Inselspital, CH-3010 Bern, Switzerland
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)83295-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1675
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [41] THE ENTEROINSULAR AXIS - GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE (GLP-1(7-36)AMIDE) - A NEW INCRETIN CANDIDATE
    GOKE, R
    GOKE, B
    RICHTER, G
    ARNOLD, R
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1988, 26 (11): : 715 - 719
  • [42] LONG-TERM ADMINISTRATION OF GLP-1(7-36)AMIDE TO NORMAL AND NIDDM RATS
    KAWAI, K
    OHASHI, S
    WATANABE, Y
    YOKOTA, C
    SUZUKI, S
    YAMASHITA, K
    DIABETOLOGIA, 1993, 36 : A47 - A47
  • [43] POTENT GLYCOGENIC EFFECT OF GLP-1(7-36)AMIDE IN RAT SKELETAL-MUSCLE
    VILLANUEVAPENACARRILLO, ML
    ALCANTARA, AI
    CLEMENTE, F
    DELGADO, E
    VALVERDE, I
    DIABETOLOGIA, 1994, 37 (11) : 1163 - 1166
  • [44] GLIP (GLP-1(7-36)amide) tablet lowers blood glucose in humans.
    Ahren, B
    Larsson, H
    Heiber, S
    Juneskans, O
    Holst, JJ
    Gutniak, MK
    DIABETES, 1996, 45 : 96 - 96
  • [45] Stimulation of pulsatile secretion of insulin and GLP-1(7-36)amide following by oral glucose
    Balks, HJ
    Holst, JJ
    Brabant, G
    VonzurMuhlen, A
    DIABETOLOGIA, 1997, 40 : 495 - 495
  • [46] GLP-1(7-36) and GLP-1(9-36) protect murine hearts from post-ischemic contractile dysfunction
    Kolibash, Christopher P.
    Chen, Christine A.
    Mu, Anbin
    Brown, Suzanne B.
    Shannon, Richard P.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S1 - S1
  • [47] In Vitro Metabolism of the Glucagon-Like Peptide-1 (GLP-1)-Derived Metabolites GLP-1(9-36)amide and GLP-1(28-36)amide in Mouse and Human Hepatocytes
    Sharma, Raman
    McDonald, Thomas S.
    Eng, Heather
    Limberakis, Chris
    Stevens, Benjamin D.
    Patel, Sheena
    Kalgutkar, Amit S.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2148 - 2157
  • [48] GLP-1 (7-36amide) is transformed by dipeptidyl peptidase IV in the capillaries supplying the L-cells into GLP-1 (9-36amide), which antagonizes the gastrointestinal effects of GLP-1
    Holst, JJ
    Hansen, L
    Orskov, C
    Wojdemann, M
    Wetiergren, A
    Deacon, CF
    DIABETES, 1998, 47 : A30 - A30
  • [49] GLP-1 (9-36)amide does not antagonise the insulinotropic effect of GLP-1 (7-36)amide in anaesthetised pigs, but reduces blood glucose by a mechanism that does not involve insulin secretion
    Deacon, CF
    Holst, JJ
    DIABETES, 2001, 50 : A31 - A32
  • [50] Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM
    Nauck, MA
    Wollschlager, D
    Werner, J
    Holst, JJ
    Orskov, C
    Creutzfeldt, W
    Willms, B
    DIABETOLOGIA, 1996, 39 (12) : 1546 - 1553
12345